BK1188 Post-pandemic Stocks
- 415.741
- -2.501-0.60%
Nomura Adjusts CSPC Pharmaceutical's Price Target to HK$10.07 From HK$9.41, Keeps at Buy
Nomura Adjusts JD Health's Price Target to HK$44 to HK$37, Keeps at Buy
Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$6.16 From HK$6.63, Keeps at Buy
Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$9.41 From HK$8.98, Keeps at Buy
Nomura Adjusts Sinopharm Group's Price Target to HK$32.39 Form HK$33.31, Keeps at Buy
Nomura Adjusts JD Health International's Price Target to HK$44 From HK$60, Keeps at Buy
Nomura Adjusts JD Health's Price Target to HK$60 From HK$75, Keeps at Buy
Nomura Adjusts JD Health's Price Target to HK$75 From HK$87, Keeps at Buy
Nomura Adjusts CSPC Pharmaceutical's Price Target to HK$10.63 From HK$11.27, Keeps at Buy
Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$11.27 From HK$11.14, Keeps at Buy
UBS Adjusts Shanghai Junshi Biosciences' Price Target to HK$65.40 From HK$70.90, Keeps at Buy
Alibaba Health Information Technology Ltd. Raised to Outperform From Hold by Daiwa Capital Markets
UBS Adjusts CanSino Biologics' Price Target to HK$88 From HK$200, Keeps at Buy
UBS Adjusts Sinopharm Group's Price Target to HK$26 From HK$28, Keeps at Buy
UBS Adjusts CSPC Pharmaceutical Group's Price Target to HK$11.80 From HK$13, Keeps at Buy
UBS Adjusts Sino Biopharmaceutical's Price Target to HK$7.5 From HK$8, Keeps at Buy
UBS Adjusts Ping An Healthcare and Technology's Price Target to HK$23 From HK$28, Keeps at Neutral
Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$7.78 From HK$8.19, Keeps at Buy
Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$11.14 From HK$11.20, Keeps at Buy
Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$11.2 From 11.64, Keeps at Buy